<unk> , sold under the brand name Kerendia, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type2 diabetes.<unk>  is a non-steroidal mineralocorticoid receptor antagonist (MRA). Common side effects include hyperkalemia (high levels of potassium), hypotension (low blood pressure), and hyponatremia (low levels of sodium).<unk>  was approved for medical use in the United States in July 2021, and in the European Union in February 2022.
Finerenone
Androstanolone
Lynestrenol
Androstanolone valerate
Allylestrenol
Androstanolone enanthate
Androstanolone propionate
Protollin